Epigenetics Market: Research Strategies with Share Analysis, Top Key Players with Opportunities Forecast to 2027

The demand for epigenetic solutions is witnessing an uptick on account of rising GDP per capita, household disposable income leading to the raised standard of living, and sedentary lifestyle. As a result, there is an increase in incidences of cancer and other age-related diseases among the rapidly growing geriatric population all over the world. Thereby, augmenting the growth of the epigenetics market all over the world. For instance, worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Furthermore, rare diseases currently affect 3.5%-5.9% of the worldwide population.

Furthermore, The global epigenetics market is expected to witness a boost owing to the rising government funding and initiatives for epigenetics research. One such example is the epigenomics project of NIH which was supported by common fund from 2008 to 2017. this program generated a set of reference epigenomics & research tools, technologies, datasets & infrastructure that accelerated our understanding chemical modification in DNA regulates the gene activity without altering the sequence of DNA and what is the role of theses modification in health & disease.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=4828

As of March 16, 2021, there have been almost 121 million cases of COVID-19 worldwide. The disease has impacted more than 210 countries and territories, with the United States confirming around one-fifth of all global cases. Therefore, it has become imperative to decipher the transmission chain of the virus which in turn will help in controlling the spread of this virus. Owing to these facts, there has been surge in the use of targeted antiviral therapies including remdesivir, ribavirin and other epigenetic drugs (for eg. BRD4 inhibitors, DNMT1 inhibitors, & HDAC inhibitors) as they have potential to inhibit the function of coronavirus. Therefore, many researches around the world are focusing on epigenetics research as it may prevent proliferation of virus and can help in developing therapeutics against this virus.??

According to UnivDatos Market Insights (UMI)’ research report “Global Epigenetics Market Analysis, 2020”, the epigenetics market is projected to grow at a CAGR of XX% during 2021-27F. A rise in seed funding and series funding is one of the prominent reason which is driving the market of the epigenetics. For instance, Chronomics, a consumer epigenetic testing start-up founded in 2017, has secured nearly USD 1.53 million in seed funding, including investment from Anthemis and follow on funding from global venture capital firm SOSV.?

Based on the Application, the oncology segment acquired the major market share and grabbed US$ XX Mn revenue from the epigenetics market in 2020 and is also expected to maintain its dominance and grow at the CAGR of XX% during the forecast period owing to many companies are focusing on developing cancer therapies using epigenetic biomarkers. For instance, recently in 2021, Mnemo Therapeutics raised USD 88.3 million in the largest-ever French Series A round. The company intent to use it to develop CAR-T cell immunotherapies for cancer using epigenetic targets.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=4828 ?

Biotechnology & Pharmaceutical Companies Among End-Users to Witness Robust growth

Based on the end-users, the market is divide into pharmaceutical & biotechnology companies, academic & research institutes, contract research organization, and others. The pharmaceutical & biotechnology companies grabbed XX% revenue share in 2020. The market size of this segment touched US$ XX Million in 2020. The market share of the segment is expected to maintain its dominance in the forthcoming years as well owing to the growing number of pharmaceutical & biotechnology companies all over the world. ?

North America to Grab Lion’s Share, Asia-Pacific to register the fastest growth

Based on the Region, North America dominated the global epigentics market in 2020. The region is projected to maintain its dominance during the forecasted period 2021-27 owing to the number of well-established players in the region and heavy expenditure on R&D in the epigenetics sector leading to the development and launch of novel products. However, Asia-Pacific is expected to skyrocket with a CAGR of XX% in the forecast period owing, as stated in UnivDatos Market Insights (UMI)’ research report “Global Epigenetics Market Analysis, 2020”.??

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the global epigenetics market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, Merck & co, Abcam PLC, Active Motif, Diagenode, among others. The players are focused on launching new products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry. Some of the instances are:

§?In 2021, Twist Biosciences launches NGS methylation detection system for epigenetic studies and liquid biopsy cancer cancer analysis.

§?In 2020, 10x Genomics was the first company to market its Chromium Single Cell Multiome ATAC + Gene Expression solutions which are capable of simultaneously profiling epigenome and transcriptome from the same single cell. ?

“Global Epigenetics Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for epigenetic solutions providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.??????

For more informative information, please visit us – ?https://univdatos.com/report/epigenetics-market/

Market Segmentation:

1.?????By Product/Services (Enzymes, Instruments, Reagents, Kits, and Others)

2.?????By Application (Oncology, Metabolic diseases, Immunology, Developmental biology, Cardiovascular diseases, and Others)

3.?????By End-Users (Pharmaceutical and Biotechnology Companies, Academic & research institutes, Contract research organizations, and Others)

4.?????By Region (North America, Europe, Asia-Pacific, Rest of the World)

5.?????By Company (Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, Merck & co, Abcam PLC, Active Motif, Diagenode, etc.)

Key questions answered in the study:

1.?????What are the current and future trends of the Global Epigenetics industry?

2.?????How the industry has been evolving in terms of end-user demand, application and product areas?

3.?????How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.?????What are the key growth drivers and challenges for the Epigenetics industry?

5.?????What are the customer orientation, purchase behavior, and expectations from the Epigenetics firms across various regions??